APA (7th ed.) Citation

Kelsen, S. G., Agache, I. O., Soong, W., Israel, E., Chupp, G. L., Cheung, D. S., . . . Brightling, C. E. (2021). Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. Journal of allergy and clinical immunology, 148(3), 790-798. https://doi.org/10.1016/j.jaci.2021.03.044

Chicago Style (17th ed.) Citation

Kelsen, Steven G., et al. "Astegolimab (anti-ST2) Efficacy and Safety in Adults with Severe Asthma: A Randomized Clinical Trial." Journal of Allergy and Clinical Immunology 148, no. 3 (2021): 790-798. https://doi.org/10.1016/j.jaci.2021.03.044.

MLA (9th ed.) Citation

Kelsen, Steven G., et al. "Astegolimab (anti-ST2) Efficacy and Safety in Adults with Severe Asthma: A Randomized Clinical Trial." Journal of Allergy and Clinical Immunology, vol. 148, no. 3, 2021, pp. 790-798, https://doi.org/10.1016/j.jaci.2021.03.044.